Podcasts about American Urological Association

Developed by the Society of Academic Urologists in partnership with the American Urological Association, the SAU/AUA Urology Match Insider series provides medical students interested in the field of urology an inside look into the Urology Residency Match process. In part 1 of this episode, medical student, Vivian Wang, sits down with Dr. Gina Badalato and Dr. Erica Traxel to discuss what students need to know about the Match, including timeline, dos and don'ts for applicants and what to expect during the process.

Featuring perspectives from Dr Daniel George, Dr Leonard G Gomella and Dr Evan Y Yu, moderated by Dr George, including the following topics: Introduction (0:00) Current Treatment Landscape for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) — Dr Gomella (3:42) Clinical Implications of and Appropriate Strategies to Identify PTEN Deficiency in Prostate Cancer — Dr Yu (35:37) Emerging Role of AKT Inhibition for mHSPC — Dr George (1:06:18) CME information and select publications

Dr Leonard G Gomella from the Sidney Kimmel Cancer Center in Philadelphia, Pennsylvania, Dr Evan Y Yu from the Fred Hutchinson Cancer Center in Seattle, Washington, and Dr Daniel George from Duke Cancer Institute in Durham, North Carolina, discuss important clinical datasets and patient cases relevant to AKT inhibition in the care of patients with prostate cancer. CME information and select publications here.

At the American Urological Association's 2025 Annual Meeting in Las Vegas, Dr. Félix Guerrero-Ramos (ES) presented the first results from cohort 4 of the SunRISe-1 study, assessing TAR-200 monotherapy in patients with Bacillus Calmette-Guérin (BCG) - unresponsive papillary-only high-risk non-muscle-invasive bladder cancer.In this episode, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Guerrero-Ramos about the study's design, a detailed discussion of the results, comparisons with other trials such as BOND-003, and the implications for clinical practice. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

On this episode, Dr. Sadaf breaks down everything you need to know about the newly released American Urological Association guidelines on Genitournary Syndrome of Menopause (GSM). Learn all about this common condition that is caused by low estrogen after menopause, how doctors diagnose GSM, and what symptoms it comes with. This episode is a full breakdown of these new guidelines that are essential towards providing women and their providers with valuable insights and strategies for effectively treating GSM.You can read the new GSM guidelines here: https://www.auanet.org/guidelines-and-quality/guidelines/genitourinary-syndrome-of-menopauseDisclaimer: Anything discussed on the show should not be taken as official medical advice. If you have any concerns about your health, please speak to your medical provider. If you have any questions about your religion, please ask your friendly neighborhood religious leader. It's the Muslim Sex Podcast because I just happen to be a Muslim woman who talks about sex.To learn more about Dr. Sadaf's practice and to become a patient visit DrSadaf.comLike and subscribe to our YouTube channel where you can watch all episodes of the podcast!Feel free to leave a review on Apple Podcasts and share the show!Follow us on Social Media...Instagram: DrSadafobgynTikTok: DrSadafobgyn

Guest: Ihtisham Ahmad Preclinical findings in animal models have shown that activating cannibinoid receptors can shrink prostate tumors in animal models. To explore whether these effects translate to human populations, a recent study examined a potential link between cannabis use and the development of prostate cancer. Hear from Ihtisham Ahmad, a fourth-year medical student at the University of Toronto, as he explains the methodology and findings from his research, which he presented at the American Urological Association 2025 Annual Meeting.

In this episode, Dr. Geo shares a practical guide to choosing the right prostate cancer treatment. Broadcasting from the American Urological Association meeting in Las Vegas, he explains how to navigate overwhelming advice, ask better questions, and make confident, informed decisions based on your diagnosis, values, and personal goals.Key Learning Points:Why it's important to gather multiple opinions before deciding on a treatment.How to weigh treatment options based on potential cure rates and side effects.The role of your personal values and intuition in making the final decision.Why bringing a supportive partner to medical visits can make a big difference.How lifestyle medicine can help reduce the risk of recurrence after treatment.________________________ Introducing The Dr. Geo Prostate Podcast Exclusive MembershipWe'll continue bringing you powerful weekly episodes to support your prostate health journey. But if you're ready to dive deeper, the Exclusive Membership gives you more: curated transcripts, detailed show notes, expert resources, and member-only perks—all designed to help you live better with age. Join HERE [https://drgeo.com/membership]_________________________ Thank you to our partnersThe ProLon 5-Day Fasting Mimicking Diet is a plant-based meal program designed to provide fasting benefits while allowing food intake. Developed by Dr. Valter Longo, it supports cellular renewal, fat loss, and metabolic health through low-calorie, pre-packaged meals that keep the body in a fasting state.Special Offer: As a listener, you can get the ProLon kit for just $148 using this [https://bit.ly/3TVehAx ].We'd also like to thank our partner AG1 by Athletic Greens. AG1 includes 75 high-quality vitamins, minerals, whole-food sourced ingredients, probiotics, and adaptogens to help you start your day right. This blend supports your gut, immune system, energy, focus, and more—all in one daily scoop. https://bit.ly/3mA2tVV_________________________

Guest: Wayne Kuang, MD In an exciting time for diagnostics and therapeutics in urology, the discussions at the American Urological Association's 2025 Annual Meeting are redefining the landscape of men's health. Dr. Wayne Kuang, CEO of MD for Men in Albuquerque and Founder of the ManVsProstate campaign, highlights some of the most anticipated topics at this year's conference, including prioritizing early intervention, preserving vitality, and expanding the focus beyond the prostate to protect the bladder.

In today's episode of The Root Cause Medicine Podcast, Dr. Carrie Jones sits down with Dr. Rena Malik to tackle the often-taboo subject of sexual health and its crucial role in overall well-being. 1. Why sexual health is still a taboo in modern medicine 2. What society gets wrong about sex 3. How to talk about sexual health with your doctor 4. The link between erectile dysfunction and heart attacks 5. How everyday medications could be impacting your libido Dr. Malik is a board-certified urologist with specialized training in Female Pelvic Medicine, Reconstructive Surgery, and Sexual Medicine, along with certification as a Menopause Society Practitioner. Recognized as the American Urological Association's Young Urologist of the Year in 2023, Dr. Malik runs a popular YouTube channel, ranked in the Top 500 Educational Channels, where she is committed to making healthcare education accessible. She is also a sought-after speaker, digital opinion leader, and podcaster. Order tests through Rupa Health, the BEST place to order functional medicine lab tests from 30+ labs - https://www.rupahealth.com/reference-guide

Not necessarily a fun 'sode to do, but we wanted to revisit The IC Solution - written almost 10 years ago now - to see what we got wrong or would change if we wrote another edition.We talk about the book-writing process, how we wrote a good chunk of it in a oceanfront pool in Mexico, and what our goal was for patients.The book has been the best-seller in it's Amazon category and reached nearly 25,000 patients.  And it's something we're incredibly proud of.A lot of things in the book changed opinions or have aged really well.  The American Urological Association added our 'no kegels' rule for treating patients with IC to their 2022 Guidelines.  We showed in the book the evidence for Elmiron helping patients was very weak and almost certainly didn't outweigh the side effects. There was a major emphasis in the book on 'nervous system upregulation', which we would now call more 'central sensitization', even before much of that research came out.But three things we got wrong (or would do differently if we wrote it today):Using more 'trigger point' language than we would today.  As it's a patient-focused book we might have left the term in, but our explanation of it would have been very different and focused more on global overactivity.Vaginal estrogen.  If written today, with all the research that has been done, this likely would have it's own chapter or a long section.  We didn't have any mention of it in the book.How to find a great pelvic therapist.  Our goal for the book was to get people with IC to go to a pelvic therapist.  We didn't put in resources for helping them find one who was a great fit or give them the right questions to ask. Hope this has been helpful to see how opinions evolve and change.  Anything you put out into the world won't be perfect in 10 years - just put it out!PelviCon Recordings - 1 Day Flash SaleIf you missed the PelviCon recordings, we're doing a 1-day flash sale with a portion of the proceeds benefitting Hurricane Helene relief.  You have less than 24 hours - here's the link!  www.pelvicon.com/recordingAbout UsNicole and Jesse Cozean founded Pelvic PT Rising to provide clinical and business resources to physical therapists to change the way we treat pelvic health.   PelvicSanity Physical Therapy (www.pelvicsanity.com) together in 2016.  It grew quickly into one of the largest cash-based physical therapy practices in the country.Through Pelvic PT Rising, Nicole has created clinical courses (www.pelvicptrising.com/clinical) to help pelvic health providers gain confidence in their skills and provide frameworks to get better patient outcomes.  Together, Jesse and Nicole have helped 600+ pelvic practices start and grow through the Pelvic PT Rising Business Programs (www.pelvicptrising.com/business) to build a practice that works for them! Get in Touch!Learn more at www.pelvicptrising.com, follow Nicole @nicolecozeandpt (www.instagram.com/nicolecozeandpt) or reach out via email (nicole@pelvicsanity.com).Check out our Clinical Courses, Business Resources and learn more about us at Pelvic PT Rising...Let's Continue to Rise!

Robert E. Brannigan, MD, expands on the American Urological Association and American Society for Reproductive Medicine's 2024 amendment to the male infertility guideline. As chair of these guideline amendments, Dr. Brannigan delves into recommendation updates, as well as their effect on diagnostic processes and how male infertility is evaluated.

Jennifer U. Miles-Thomas, MD, a trailblazing urologist and advocate for gender diversity in the field, shares her personal journey, from her specialization in female reconstructive surgery to her recent appointments as vice chair – Regional Integration and Innovation and assistant professor of Urology at Northwestern Medicine, and as treasurer-elect of the American Urological Association. As an expert in the field, Dr. Miles-Thomas sheds light on her unique approaches to her practice and discusses obstacles that hinder gender diversity in urology. She discusses her vision for the future of gender diversity in urology and how it can positively impact patient care and outcomes.

Our guest is Dr. Daniel Lin, a urologist, professor and Chief of Urologic Oncology at the University of Washington and professor of the Division of Public Health Sciences at the Fred Hutchinson Cancer Center. The goal of this podcast is to help patients and caregivers learn how prostate imaging is used to detect prostate cancer. Dr. Lin talks about prostate imaging as it relates to the American Urological Association, or AUA, clinical guidelines. Our hope is that this podcast will help patients to better talk with their doctors so they can make informed decisions about their prostate health and care. This podcast was sponsored in part by Blue Earth Diagnostics. For more information, please visit www.UrologyHealth.org and don't forget to subscribe to our free digital magazine, UrologyHealth extra® at www.urologyhealth.org/uhe. **** September 12, 2024

In this 30-minute CME episode of Better Edge, Robert E. Brannigan, MD, professor of Urology at Northwestern Medicine and the guideline amendment chair at the American Urological Association, expands on the 2024 amendments to AUA's guideline for male infertility.He delves into the specific updates made to the recommendation on evaluating azoospermic patients and how these updates impact the diagnostic process. Additionally, Dr. Brannigan explains the changes in the recommendation on karyotype testing and how they contribute tothe evaluation of male infertility and explores the implications of the updates regarding the use of imaging modalities when evaluating patients.

In this episode, we discuss treatment of acute ischemic priapism, including some updates from the American Urological Association.    Show notes and references: FOAMcast.org

In Episode 6, Drs. Aly-Khan Lalani and Christopher Wallis are joined by The View on GU's first guest Dr. Diana Magee to discuss why location matters when it comes to medical conferences. They touch upon Dr. Magee's recent article in The Journal of Urology, and consider the ethical, economic and political implications of the upcoming American Urological Association conference in Texas following implementation of the state's abortion ban. The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practicing clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: https://theviewongu.com This podcast has been made possible through financial support by Bristol Myers Squibb, Merck, and TerSera. The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the position of hospital corporations and are not intended to be personal medical advice.

Lisa is joined by Karyn Eilber, MD who talks about five reasons why exercise is good for sexual health and much more!Karyn Eilber, MD: Board Certified in both Urology and Female Pelvic Medicine and Reconstructive SurgeryAssociate Professor of Urology and Obstetrics and Gynecology, Associate Director of the Urology Residency Training Program, and Co-director of the Female Pelvic Medicine and Reconstructive Surgery Fellowship Training Program at Cedars-Sinai Medical Center in Los AngelesInvited lecturer and presenter at local, national, and international conferences on the subjects of male and female voiding dysfunction, female sexual dysfunction, and pelvic reconstructive surgeryDr. Eilber is one of only 9% female urologists in the United States and is board certified in both Urology and Female Pelvic Medicine and Reconstructive Surgery. She is an Associate Professor of Urology and Obstetrics and Gynecology at Cedars-Sinai Medical Center in Los Angeles where she is also the Associate Director of the Urology Residency Training Program and Co-director of the Female Pelvic Medicine and Reconstructive Surgery Fellowship Training Program. Prior to joining Cedars-Sinai, Dr. Eilber practiced at Memorial Sloan-Kettering Cancer Center where she gained extensive experience in pelvic reconstruction following cancer treatment. Also at that time, she held a dual appointment as an Assistant Professor at Weill Medical College at Cornell University. Dr. Eilber's clinical and research focus has been in the areas of urogynecology and voiding dysfunction. She has published multiple peer reviewed manuscripts and is co-editor of The Use of Robotic Technology in Female Pelvic Floor Reconstruction . In addition to being a member and past-president of the Los Angeles Urologic Society, Dr. Eilber is a member of the American Urological Association, the Society of Urodynamics, Female Pelvic Medicine & Urogenital reconstruction, and the Society of Women in Urology. She is an invited lecturer and presenter at local, national, and international conferences on the subjects of male and female voiding dysfunction, female sexual dysfunction, and pelvic reconstructive surgery.

Interstitial cystitis (IC) is a scary and incredibly misunderstood diagnosis.  You may have also heard terms like ‘painful bladder syndrome' or ‘bladder pain syndrome' as well.  We want to shed some light on what IC is, how it's diagnosed and what you can do about it!Definition of IC:  Interstitial cystitis is defined by the presence of two symptoms in the absence of any other explanation (like a UTI or bladder cancer).  It's:Pain or pressure we perceive to be related to the bladder, and Urinary urgency or frequencySymptoms of IC:  In addition to the hallmark symptoms of bladder pain and urinary urgency/frequency, people often have other related issues.  These can include painful intercourse, low back pain, having to go to the bathroom at night (nocturia), pain with sitting or exercise, constipation and other pelvic health symptoms. Do I really have interstitial cystitis?  IC is a diagnosis of exclusion, which means it's only diagnosed by ruling out other things (like bladder cancer or a UTI).  There's no test that can confirm you have IC (including a cystoscopy).  If you have the symptoms above - pelvic pain perceived to be related to the bladder and urinary urgency/frequency - you can be diagnosed with IC just by the symptoms.Importantly, the IC diagnosis doesn't tell you anything about WHY you have the symptoms or WHAT the best treatment option will be for you!Physical Therapy for Interstitial Cystitis.  The muscles and nerves of the pelvic floor can be responsible for every symptom of IC.  They can cause the bladder pain and urinary symptoms.  They are also the cause of seemingly unrelated symptoms like painful intercourse, low back pain, hip pain or constipation.  It's the reason symptoms are often worse when sitting or after strenuous exercise, and why they can get better after gentle stretching or a warm bath.Physical therapy is the highest recommended treatment (Grade ‘A') by the American Urological Association.  It's literally the first recommendation you should get from a urologist when IC is suspected.  We hope this gives you a good overview of the condition, and we want to leave you with the first lines of The IC Solution (link): “Thousands of people with IC live healthy, happy and pain-free lives - and so can you!”About UsDr. Nicole and Jesse Cozean are the founders of PelvicSanity Physical Therapy (www.pelvicsanity.com) in Southern California. The clinic has helped thousands of patients in the Orange County, CA area and hundreds from around the world with a remote consultation and Out of Town Program.They co-authored The IC Solution and Nicole created The IC Roadmap online course to provide the most accurate, up-to-date information for those with interstitial cystitis. They run the Finding Pelvic Sanity Facebook group for a supportive online community for anyone dealing with pelvic health issues.Nicole has also created courses and trained thousands of pelvic PTs to provide better care through her work with Pelvic PT Rising (www.pelvicptrising.com). Subscribe to the podcast Follow @pelvicsanity for great info! Join the Finding PelvicSanity support group Check out www.pelvicsanity.com for additional help! And as always, we hope this has helped you find just a bit of pelvic sanity!

Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs CME Available: https://auau.auanet.org/node/39485 Release Date: December, 2023 Expiration Date: December, 2024 LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to: 1. Describe health care costs associated with prostate biopsy infections. 2. Identify the steps where modifications in technique can reduce the risk of complications. 3. Apply modified technique at various steps of the procedures to mitigate the risk of complications. ACKNOWLEDGEMENT Project Firstline is a national collaborative led by the U.S. Centers for Disease Control and Prevention (CDC) to provide infection control training and education to frontline health care workers and public health personnel. AMA has partnered with Project Firstline, as supported through Cooperative Agreement CDC-RFA-CK20-2003.  The American Urological Association is proud to collaborate with AMA and Project Firstline in this educational activity.  CDC is an agency within the Department of Health and Human Services (HHS). The contents of this event do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the Federal Government.

Health Insurance continues to be a very complex, difficult to understand and in many instances less than transparent entity.    This episode explores health insurance from multiple perspectives (individuals, employers, health care providers and care delivery organizations.    The role of Pharmacy Benefit Managers (PBM's) is also explored   Guest:   Dr Jeffrey Frankel, MD,  Is a Past President of the Washington State Urology Society, a Past President of the Western Section of the American Urological Association, a Past President of the American Association of Clinical Urologists, and he currently chairs the Government Affairs Committee for the Washington State Urology Society He has practiced Urology in the King County area since1985. During This Episode We Discuss:   What is your responsibility regarding your insurance coverage prior to visiting a medical providers office, undergoing a procedure or study and or surgery.   How does your coverage differ from someone else who might be under the same plan   What happens when you are in Network or out of Network.. What does that mean?   What happens when you care provider becomes employed by a healthcare entity, clinic or insurance company   How does Medicare, Medicaid work? How is it different from private insurance?   What are Medicare advantage plans?   What are Pharmacy Benefit Managers?      Recommended Resources:   Episode 17 Understanding and Navigating the health Insurance System, The Original Guide to Men's Health  

Dr. David Penson, Chair of the Department of Urology at Vanderbilt University, discusses his comparative effectiveness research in prostate cancer. He talks about the evolution of Prostate Cancer awareness in the US, and historic screening and side effect issues that have made it a stigmatized topic for many men. Dr. Penson describes the nuances of PSA testing and how higher diagnosis rates of Prostate Cancer has led to overtreatment in the past, and the current shift to focus on active surveillance is helping to better balance the treatment paradigm for men with Prostate Cancer. Key Highlights: What is comparative effectiveness research and why does it matter to cancer patients? The evolution of the stigma associated with Prostate Cancer. How to think about the nuances of PSA screening tests. About our guest: David F. Penson, MD, MPH is the Hamilton and Howd Chair in Urologic Oncology, Director of the Center for Surgical Quality and Outcomes Research and Professor and Chair, Department of Urology at Vanderbilt University. He currently maintains a clinical practice in urologic oncology at the Vanderbilt-Ingram Cancer Center.  While his general research focus is clinical epidemiology and health services research across all urologic disease, his specific interests include the comparative effectiveness of treatment options in localized prostate cancer and the impact of the disease and its treatment on patients' quality of life. Key Moments: 6 minutes: What is CER and why does it matter? “Comparative effectiveness research has been around forever. People have different names for it, but it's comparing the effectiveness of various interventions for a condition. I've been focused in prostate cancer, so a lot of what I'm focused on is comparing the effectiveness of surgery and radiation and, for that matter, active surveillance in outcomes in prostate cancer.” 21 minutes: How cultural differences impact stigma. “In the US, prostate cancer is much more common in Black men. And the way they respond to the diagnosis may be different than other cultural groups. Hispanic men have another way of looking at it, white men, etc. So you do have this cultural element to it too, because sexuality and body image is often tied to cultural norms.” 31 minutes: The nuances of PSA screening. “The American Urological Association just came out with new recommendations around screening and does say, discuss screening, but doesn't say everyone should be screened. They've sort of started talking about getting a PSA test in your mid-40s, because there's pretty good literature that a baseline PSA test will establish your pretest probability of clinically significant prostate cancer in your lifetime. But the other thing that they mentioned is they basically say we should probably not be doing annual screening with PSA testing, probably every other year. Because less may be more here.” This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features this PCORI study by Dr. Penson. Visit the Manta Cares website  Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard, or delay in obtaining, medical advice for any medical condition they may have, and should seek the assistance of their health care professionals for any such conditions. --- Support this podcast: https://podcasters.spotify.com/pod/show/manta-cares/support

Chronic Pelvic Pain, Chronic Prostatic Pain Syndrome, Chronic Testicular and Penile Pain often have origins in abnormal pelvic floor muscle tension. Listen and find out how modern pelvic physical therapy can help. Guests:   Molly Riley, PT,DPT: Pelvic Health Physical Therapist, University of Washington,Northwest Outpatient Medical Center   Ken Berger, JD, MD: President of the Washington State Urology Society,  Practicing Urologist, Tri-State Health,Clarkso,WA, Chair of American Urological Association's Leadership and Business Education Committee. During This Episode We Discuss: The Evaluation and Management of Chronic Pelvic, Prostatic, Testicular, and Penile Pain.  Management of the abnormal voiding ( the non relaxing voider ), improving post operative stress urinary incontinence, and appropriate technique for strain free bowel evacuation.   Chronic Prostatitis is now referred to as Chronic Pelvic Pain Syndrome (CPPS): This is an effort to change thinking that all chronic prostatitis is infection oriented. Many times CPPS patients respond very nicely to pelvic floor PT   Quotes: Referring to the steps in evaluating testis pain….” If I do all of that and I don't find anything, that becomes a much more difficult problem for me as a Urologist to treat. That is where I start thinking about sending ( the patient ) to Physical Therapy.                                                                                                                                                                                  Dr. Ken Berger, JD, MD. Recommended Resources: Pelvicrehab.com:  Use this as a resource to find a Pelvic Health Physical Therapist  

Two cracking bladder cancer studies to discuss on GU Cast today (in our brand new GU Cast studio)! We are joined by Dr Sia Daneshmand, Urologist and Director of Urologic Oncology at the University of Southern California, who presented the headline-making Tar-200/SunRIse-1 study at the recent Annual Meeting of the American Urological Association. Not sure what a urological pretzel is and how it can help patients with high-grade non-muscle-invasive bladder cancer? Sia explains all! He was also an investigator on the SWOG 1011 trial presented at the ASCO Annual Meeting recently by Dr Seth Lerner. A practice-changing randomised trial of standard vs extended pelvic lymph node dissection for patents with invasive bladder cancer. These are very significant papers and we really enjoyed having Sia on GU Cast to discuss. Even better on YouTube when you can check out our new studio!

We are excited to share the highly anticipated second part of our riveting technology highlights podcast series, broadcasting straight from the heart of the annual American Urologic Association meeting in Chicago, Illinois! The world of BPH treatment options is booming with innovation! Get ready for an exclusive sneak peek into several upcoming technologies Dr. Pohlman discovered while scouring the exhibition hall at the American Urologic Association annual meeting.  This week, we focus on the incredible advancements in BPH technology and share insightful interviews with representatives from pioneering companies and urologists utilizing these cutting-edge tools. While we will only scratch the surface of the fan favorites at this year's conference, you can rest assured we will keep you up to speed on other ground-breaking technologies throughout the year! Get ready to stay ahead of the curve on our podcast journey! In this episode, we dive into the intriguing world of cutting-edge solutions for an enlarged prostate, known as benign prostatic hyperplasia or BPH. Prepare yourself for an exclusive glimpse behind the scenes as we uncover the latest advancements that will revolutionize prostate management. Whether you are concerned about your own health or that of a loved one, this is an episode you cannot afford to miss! Join us as we unlock the mysteries of prostate health and equip you with the knowledge to navigate this crucial aspect of well-being! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Pohlman is already utilizing Optilume BPH for managing urethral strictures in his practice. He explains how it works. Dr. Pohlman talks with Ian Schorn, Vice President of Clinical Affairs at Urotronic, about using Optilume for managing BPH. Ian Schorn explains something unique about Optilume BPH. The clinical data on the Optilume device has shown very good outcomes in terms of flow rate improvement after treatment. Urotronic hopes to get official FDA approval within the next few months for its Optilume technology. Dr. Pohlman shares the secret to the successful results of Optilume. Dr. Pohlman describes the new stent devices now emerging for BPH and explains which ones will most likely rise to the top, in terms of outcomes and urologist preference. Dr. Pohlman talks to the CEO of Butterfly Medical, Idan Geva, about their new technology for BPH. How does Butterfly Medical's new nitinol implant compare with other available technologies? What is Aquablation therapy?  Dr. Lewis Kriteman, from Georgia Urology, discusses the benefits of Aquablation therapy and explains how it compares with the procedures he used before. Dr. Pohlman was the first urologist in the Seven State Region, including Nebraska, Kansas, Iowa, Missouri, Montana, Wyoming, and Colorado, to offer Aquablation. It is encouraging and exciting to see the continuous advancements in technology and techniques for managing BPH! Today's tantalizing glimpse into emerging technologies at the AUA annual meeting is just the beginning. We will delve even deeper into these breakthroughs in future episodes.  Stay connected by subscribing to our podcast to ensure you are always in the loop, and get ready for a journey of knowledge and discovery as we explore the forefront of BPH management! Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Urotronic  Butterfly Medical Georgia Urology

Sponsored by TrackableMed Go behind the scenes of the American Urological Association Annual Meeting and discover why some physicians choose to embrace new technology and dive head first into learning despite their peers' reluctance to change. In this week's episode, sponsored by TrackableMed, we revisit some of the most exciting tech booths from AUA with Dr. Garrett Pohlman, Urologist and host of the Prostate Health Podcast. Dr. Pohlman joined us in Chicago as we explored the technology and asked innovators to talk about their solutions. In the interview, we also discuss the value of direct-to-patient marketing, why it's important to have multiple tools to help patients with, and tactics to ensure patients return for another visit regardless of previous results. What we discuss in the episode: AUA 2023 Highlights & Takeaways If flashy booths at conferences are worth the investment The impact of direct-to-consumer marketing Why Urologists need to have more than one tool in their toolset Effective strategies to keep patients active in seeking treatment Resources from this episode:  Get the free MedTech Talk Tracks for Action Listen to the Prostate Health Podcast Social Media:  Connect with Dr. Pohlman on LinkedIn Connect with Zed on LinkedIn Connect with Clark on LinkedIn

With every passing year, we see new technologies emerge to equip urologists with better tools for combating prostate cancer. This year's annual meeting of the American Urological Association in Chicago was no exception! We are excited to take you behind the scenes today for a closer look at some of the new and upcoming technologies for diagnosing and treating prostate cancer.   Prostate cancer is one of the most common cancers. But it is also one that has seen remarkable progress in technology. Dr. Pohlman has had first-hand experience of how innovative developments in diagnosis and treatment have revolutionized how this disease gets treated. For today's episode, he interviews Dr. Amit Vohra, the President and CEO of Promaxo, Michael Waidler, the Area Business Director for Palette Life Sciences, and Dr. Fernando Bianco, from the Urology Specialist Group, in Miami Lakes, Florida, at the AUA meeting this year, about the latest technologies in the prostate cancer arena. Sit back, relax, and get ready to be amazed by what's available right now for the diagnosis and treatment of prostate cancer! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: At Promaxo, they are commercializing a portable office-based MRI for doing interventions of prostate biopsies in addition to treatments. What makes Promaxo unique when compared with other available technologies? Dr. Pohlman will now offer the Promaxo technology to patients in his practice. He explains how it works. Dr. Pohlman talks to Michael Waidler from Palette Life Sciences about a new rectal spacer to help protect healthy tissue from radiation beam exposure and reduce the long-term side effects of radiation therapy for prostate cancer. What makes Barrigel unique from a urologist and patient perspective? What do rectal spacers do? The advantage Barrigel has over other rectal spacers. Dr. Fernando Bianco highlights the benefits of targeted therapy versus active surveillance. Innovation drives progress! The advancements in prostate cancer technology are a true testament to that. Today's glimpse into the AUA annual meeting has only scratched the surface of what is to come. So, subscribe to our podcast to stay up-to-date on the latest prostate cancer diagnosis and treatment developments, and don't forget to tune in to our next episode, which will be Part Two from the AUA annual meeting in Chicago, where we will explore the exciting new technology for men with an enlarged prostate or BPH. Thanks for joining us, and see you next time! Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Promaxo Barrigel The Urology Specialist Group  

Join us as Dr. Lewis describes the UTI Risk Factors Model & discusses how the tool can be used for both neurogenic and non-neurogenic patients, primarily in the adult female patient population. Guest bio: Dr. Tamra Lewis holds board certification in Female Pelvic Medicine and Reconstructive Surgery and she currently practices at Comprehensive Urology in Chicago, IL.  Dr. Lewis received her B.A. in Biology from Luther College in 1994, and she obtained her Medical Doctorate in 1999 from the University of Iowa College of Medicine. In 2005, Dr. Lewis completed her Surgical and Urology residencies at the University of Nebraska and then went on to complete a fellowship in Female Urology and Voiding Dysfunction at Metro Urology in Minneapolis/St. Paul, MN. Dr. Lewis's professional interests include management of incontinence, voiding dysfunction, bladder prolapse, and urinary tract infections. She is a member of the American Urological Association, the Society for Urodynamics and Female Urology, the Society for Women in Urology, and The Chicago Urologic Society, where she currently serves as President. Dr. Lewis has been an invited speaker or presenter for numerous events on topics including incontinence, overactive bladder, hematuria, and urinary tract infections.  Visit  Coloplastprofessional for more offerings! 

In this episode we discuss focal therapy for the treatment of prostate cancer.  Historically, men diagnosed with localized prostate cancer have had to choose between two treatment options: surgery and radiation therapy.  Both options involve treating the entire prostate gland, regardless of the size, location, or number of cancerous tumors.  Recently, however, more localized treatment options have become available for prostate cancer that involve focally treating only the tumors, rather than the entire prostate gland.  So, what are these focal therapies?  How do they work?  What risks are involved? What advantages do they have over traditional therapies?  And, probably most importantly, how successful are they at actually curing prostate cancer?  To answer these questions and many more, we turned to a true expert. Dr. Arvin George is an Associate Professor of Urology at the University of Michigan.  After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology at the Hofstra North Shore-LIJ School of Medicine.  He remained to complete his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery.  Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health.  Dr. George's research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer. He is an active member of the American Urological Association, Society of Urologic Oncology, the Endourological Society, and the American College of Surgeons.#prostate #prostatecancertreatment #prostatecancer #focaltherapy

According to Mayo Clinic, about 50% of women suffer from urinary incontinence, the inability to control urination voluntarily. However, only 25-61% of affected women discuss this problem with their healthcare providers. The resistance to sharing these urologic issues, both men and women, stem from shame and fear of judgment. This also stands true for other medical issues confined within the intimate parts of our bodies, including sexual dysfunction (whether it be low libido and premature ejaculation) and anatomical conditions (like uterine prolapse). Today, with empathy and compassion, we bring to light the pertinent issues "down there" that one may usually hide and fear.We are joined today by Dr. Fenwa Milhouse, a board-certified urologist, pelvic surgeon, and sexual health specialist. She received her BA in Biology from The University of Texas at Austin in 2003, MD from McGovern Medical School at UTHealth in 2008, Urology residency at the University of Chicago in 2014, and Female Pelvic Medicine and Reconstructive Surgery (Urogynecology) fellowship at Metro Urology in 2020. She currently stands as the attending physician and CEO of Down There Urology, PLLC, and has been appointed to the board of the Chicago Urological Society. Dr. Milhouse also utilizes social media to destigmatize sexual conditions and demonstrate the importance of representation in medicine, on which she has garnered over 100,000 followers. She has also been featured in articles by Insider, WebMD, and The American Urological Association.Livestream Air Date: March 21, 2022Olufenwa Famakinwa Milhouse, MD: IG @drmilhouse, TikTok @yourfavoriteurologist, & Web www.yourfavoriteurologist.comFriends of Franz: IG @friendsoffranzpod & FB @friendsoffranzpodChristian Franz (Host): IG @chrsfranz & YT Christian FranzThankful to the season's brand partners: Clove, BETR Remedies, Eko, Lumify, RescueMD, Medical School for Kids, Your Skincare Expert, Twrl Milk Tea

This series of the Elevate Podcast illuminates the path scientific communication takes from teaching to diagnosis to treating all the way to changing, prolonging, and saving patient lives. External Education of a growing variety of stakeholders in healthcare by the Medical Affairs Division of Pharma and Medical Device industry reflects the critical role Education in Medicine plays in our Age of Information. The podcast features critical discussions with leading educators across healthcare from the various perspectives of pharma / biotech sponsors, program organizers, attendees, and patients with a quest to explore some of the most novel, intriguing formats of Medical Education, following their approaches to learning in our digital age as well as their current gaps or success stories. The goal of the podcast is to make medical education simpler to access, more relevant to apply across healthcare organizations, and more continuous to inspire innovation and quality.This is a first of a series of episodes that examines the podcast as one of the most effective emerging channels and formats of education in medicine. Our host, Tim Mikhelashvili, PharmD, Co-Founder and CEO of Amedea Pharma and Chair of the Mentorship Program at the Medical Affairs Professional Society (MAPS) speaks with Shelby Englert, Vice President of Education at the American Urological Association to learn why podcasts are powerful from a Professional Medical Society's perspective. Shelby explains why its organization started its AUA University podcast, now with 165 episodes and the role it has played in building and growing its community of urologists in the association. She also describes how the AUA University podcast is structured, how it has evolved over time, and shares personal suggestions for elements of education most valuable and relevant to an audience in a podcast, providing specific examples that demonstrate the direct impact of the podcast on patient and physician behaviors as well as health outcomes. Listen to this episode because it not only centers on the ultimate impact of podcasts on the quality of medical education, but also discusses all the “supporting players” and “accessories” to the podcast required such as channels, technology, and timing of podcast communication to make a podcast successful and valuable in healthcare.

In this episode, guest host Dr. David Canes interviews Dr. Matthew Allaway about PrecisionPoint, his medical device for transperineal prostate biopsy, and his journey towards changing the paradigms of prostate cancer diagnosis. The CE experience for this Podcast is powered by CMEfy - click here to reflect and earn credits: https://earnc.me/0Lmsku --- SHOW NOTES Dr. Allaway starts by outlining his path to medicine. The choice to pursue urology was largely influenced by his personal cancer diagnosis. He cites cancer as the greatest lesson in his life, since it brings an enhanced level of empathy to his patient care and inspires him to contribute to the field of urology. Throughout his career, he has always examined his procedures for logical sense – if a process was inefficient, he tried to devise ways to make improvements for patient care. In 2013, Dr. Allaway decided to switch from the transrectal to transperineal approach for prostate biopsies. With the traditional transrectal approach, he found unacceptably high rates of infection and failure to detect cancers in the anterior prostate region. He started performing transperineal biopsies with a freehand technique, using ultrasound in one hand and a biopsy probe in the other. He built a database of his own patients, which showed an increased cancer detection rate. His technique eventually evolved into the PrecisionPoint transperineal access system. He originally started marketing the device at American Urological Association (AUA) meetings, through booths and video competitions. Although Dr. Allaway works in private practice and not academia, he was able to form connections with institutions and key opinion leaders to encourage adoption of the transperineal approach. PrecisionPoint has been accepted by early adopters, and his team is now working to capture a larger share of the biopsy market. Importantly, they are also marketing the device to patients, since patients can also recognize the safety and diagnostic benefits, and being the ultimate consumers of healthcare, can influence urologists to adopt the device. Dr. Allaway also gives advice for budding entrepreneurs. He highlights the need to link the device to a specific clinical need, research existing devices, check the your device's feasibility and pricing strategy, and find good mentors who will allow you to learn from their mistakes. In terms of product marketing, he encourages entrepreneurs to look beyond the United States and explore worldwide markets to increase the chances of product adoption. His confidence in PrecisionPoint grew when he received positive feedback from other urologists about the simple elegance of the device. Finally, Dr. Allaway discusses the importance of truly believing in your product. He says that if you are ashamed of your product's price, you have priced it wrongly. He encourages entrepreneurs to focus on their product's benefit to society, rather than profitability. --- RESOURCES Precision Point: https://perineologic.com/precisionpoint/ American Urological Association: https://www.auanet.org/ Zero to One by Peter Thiel: https://www.amazon.com/Zero-One-Notes-Startups-Future/dp/0804139296

In this episode of BackTable Urology, Dr. Jill Buckley, professor of urology at UC San Diego, interviews Dr. Jack McAninch, professor emeritus of urology at San Francisco General Hospital and an international leader in the field of genitourinary trauma and reconstructive surgery. --- CHECK OUT OUR SPONSOR Laurel Road for Doctors https://www.laurelroad.com/healthcare-banking/ --- SHOW NOTES First, Dr. McAninch delineates his path to becoming a doctor. He grew up in Merkel, a small Texan town, and worked on an oil rig after high school to save money for college tuition. He attended Texas Tech University and majored in animal husbandry. After college, he received a master's degree in animal science from the University of Idaho. However, during his time in graduate school, he was required to take various pre-medical classes and discovered a passion for medicine. He applied to and received an acceptance to the University of Texas Medical Branch in Galveston. During his time in medical school, he worked as a research assistant in the plastic surgery department and discovered his interest in surgery and reconstruction. However, he chose urology as his specialty as the hours and training were less demanding than plastic surgery. He decided to enlist in the army and was sent to Letterman Army Hospital in San Francisco to complete his urology residency. During his time there, he operated on many Vietnam war soldiers and gained valuable insight in acute care and reconstructive surgery. After being stationed in Germany for 3 years, he returned to San Francisco and was recruited to San Francisco General Hospital to start a reconstructive urology program. As the only reconstructive urologist, he worked closely with the general and trauma surgeons to manage a high-volume caseload. He then went on to start the first fellowship in reconstructive urology at UCSF. Next, Dr. McAninch explains his different leadership roles throughout his career, including being an original board member of the Society of Genitourinary Reconstructive Surgeons (GURS), the president of the American Board of Urology, the president of the American Urological Association, and an important leader representing the urologic field in the American College of Surgeons. Finally, Dr. Buckley and Dr. McAninch end the discussion by reflecting on the phenomenally rapid technological advancements that have been made in the field of urology. --- RESOURCES Society of Genitourinary Reconstructive Surgeons https://societygurs.org/

When the U.S. Food and Drug Administration released a letter to healthcare providers in April 2021 announcing its investigation into numerous medical device reports involving reprocessed urological endoscopes, Dr. Seth Bechis and his colleagues set out to learn more about reprocessing and its effectiveness. They focused on flexible ureteroscopes in their research and found that, while studies assessing the effectiveness of on these specific scopes is limited, their findings line up with recent news about other flexible endoscopes — that a surprising number still harbor protein and other debris even after reprocessing, raising patient safety concerns. Their findings were published in the journal Urology. We caught up with Dr. Bechis at the American Urological Association's annual convention in New Orleans to talk more about the study. Dr. Bechis is a board-certified urologist and member of the comprehensive Kidney Stone Center at UC San Diego Health. Hes' also an Ambu consultant. Show notes: Bio: Seth Bechis Urology: “Reprocessing Effectiveness for Flexible Ureteroscopes: A Critical Look at the Evidence” Single-Use Endoscopy: “FDA Investigating Reports of Infections Associated with Reprocessed Urological Endoscopes” The FDA's Letter to Healthcare Providers: Infections Associated with Reprocessed Urological Endoscopes Single-Use Endoscopy: “Why Problems with Reprocessing Ureteroscopes ‘Haven't Gone Away'” Endoscopy Insights: Breaking Down the FDA Letter to Healthcare Providers Endoscopy Insights Show Page

Matthew Katz was at Weill Cornell Medicine when a chance digital encounter ended up steering him into urology. “If you had asked me what a urologist did before medical school I probably wouldn't have been able to answer the question,” he told me self-deprecatingly when we chatted at the American Urological Association's annual conference in New Orleans. But a blast email to the entire medical school looking for people interested in robotics research caught Katz's eye. His background in bioengineering had sparked an interest in doing something medically that was hands on, working with new technology and focusing on minimally invasive procedures. A next-generation urologist was born. Today, Katz brings a unique perspective to starting a urology practice. He's less than a year out of an endourology fellowship, has an MBA and has co-authored research on telemedicine. He also has interesting insights on the emergence of single-use endoscopes and the role they can play in urology practice going forward. Katz is affiliated with NYU Langone Health and is a clinical assistant professor in the urology department at the NYU Grossman School of Medicine.  Show notes: Bio: Matthew Katz Diseases of the Colon & Rectum: “Assessment of Ileostomy Output Using Telemedicine: A Feasibility Trial” Single-Use Endoscopy: “5 Things Urologists Were Talking About at AUA 22” Single-Use Endoscopy: “How Robotics is Shaping the Future of Urology” Endoscopy Insights Show Page

*apologies for Dr. Spitz's sound not being as high of quality as what you are use to hearing when I interview other guest. The audio does improve towards the second half of the podcast. Today I interview the author of “The Penis Book,” Urologist Dr. Aaron Spitz! Dr. Spitz is not only a urologist and author but he is also a television personality who is frequently called upon to shed light on various men’s health topics. He has appeared on Dr. Phil, the Real Housewives, and he is a frequent guest and part-time co-host on the popular CBS talk show, The Doctors. In 2018, Dr. Spitz was featured in the documentary The Game Changers on Netflix, which shed light on the game-changing effects of a plant-based diet in elite athletes. Dr. Spitz has also authored several peer-reviewed journal articles regarding the treatment for male fertility. He serves as the lead delegate representing all of America’s urologists to the American Medical Association (AMA). In 2020, the American Urological Association, presented Dr. Spitz with The Distinguished Service Award. Dr. Spitz is a national leader in health policy for urologists across the nation. We discuss his five-step plan to maximize penis health that he writes about in “The Penis Book” - A Doctor’s Complete Guide to the Penis – From Size to Function and Everything in Between. 1. Food 2. Sexercises 3. Go Offline/Porn 4. Detox 5. Sleep We also discuss: Kegel exercises for men The average man’s penis size The relationship between shoe size and penis size What is a grower and a shower Should men pee after sex? What kind of underwear should a man wear? Covid’s impact on ED The impact porn has on the brain Plant based eating Why an audio doppler is not useful in diagnosing a venous leak/erectile dysfunction The Penis Book on Amazon: The Penis Book: A Doctor's Complete Guide to the Penis--From Size to Function and Everything in Between Paperback Recommended by Dr. Spitz: The China Study on Amazon: The China Study: Revised and Expanded Edition: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss, and Long-Term Health Cookbook on Amazon: The New 2023 Engine 2 Diet Cookbook: Guide To Lowers Cholesterol, Burns Away the Pounds, Eat Plants, Lose Weight, Save Your Health The Game Changers on Netflix: https://www.netflix.com/title/81157840 About The Game Changers - Meeting visionary scientists and top athletes, a UFC fighter embarks on a quest to find the optimal diet for human performance and health. Starring: Arnold Schwarzenegger, Lewis Hamilton, James Wilks Click here to watch Dr. Spitz on the Dr.'s The Doctors TV Show Click here to visit Dr. Spitz's website Dr. Aaron Spitz Click here to learn more about Victory Men's Health For questions about today's podcast you can contact Amy Stuttle at podcast@amystuttle.com

Today's Episode Dr. Raj talks with Dr. Monish Aron about screening for prostate cancer and available treatment options.   Today's Guest Dr. Monish Aron is an expert in robotic and laparoscopic surgery for malignant and benign conditions of the prostate, kidney, bladder, adrenal gland, and the ureter. He trained in urology at premier institutions in India, Australia, and the United States. Dr. Aron completed his fellowship training in advanced robotics and laparoscopy at the Cleveland Clinic and was recruited to the University of Southern California in 2009. He has received numerous acclaimed awards including the GMOMG Medical award from the Royal College of Surgeons in Edinburgh as well as awards for his scientific presentations and surgical videos at the American Urological Association. Dr. Aron has published more than 200 publications and serves as a reviewer for 8 leading urologic journals including editorial board appointments for 3 journals. Dr. Aron has played a pioneering role in the refinement of robotic prostate and kidney surgery, single-incision laparoscopic surgery, and robotic surgery for bladder cancer. Dr. Aron has been invited to speak and demonstrate minimally invasive surgical techniques at numerous national and international institutions. About Dr. Raj Dr Raj is a quadruple board certified physician and associate professor at the University of Southern California. He was a co-host on the TNT series Chasing the Cure with Ann Curry, a regular on the TV Show The Doctors for the past 7 seasons and has a weekly medical segment on ABC news Los Angeles. Want more Dr. Raj? Check out the Beyond the Pearls lecture series! The Ultimate High Yield Bundle: The complete review of high-yield clinical medicine topics necessary for graduate medical education board exams including NBME, USMLE Steps 1/2/3, ITE and ABIM Boards. You can also listen to the Beyond the Pearls podcast. An InsideTheBoards Podcast. Check out our other shows: Crush Step 1 Step 2 Secrets Physiology by Physeo Step 1 Success Stories The InsideTheBoards Study Smarter Podcast The InsideTheBoards Podcast The Health Beat   Produced by Ars Longa Media To learn more about us and this podcast, visit arslonga.media. You can leave feedback or suggestions at arslonga.media/contact or by emailing info@arslonga.media. Produced by: Christopher Breitigan. Executive Producer: Patrick C. Beeman, MD The information presented in this podcast is intended for educational purposes only and should not be construed as professional or medical advice. Learn more about your ad choices. Visit megaphone.fm/adchoices

We first learned of Dr. Aaron Spitz from The Game Changers film. In his book, aptly named The Penis Book, Dr. Spitz states that the most common reason for erectile dysfunction is a problem with blood flow to the penis due to narrowing of the arteries. In my conversation with Dr. Spitz, we discuss the causes and what you can do to prevent and even reverse erectile dysfunction by improving penis health. Aaron Spitz, MD: Dr. Spitz earned his medical degree from Cornell Medical College, completed his Urology residency at the University of Southern California, and then obtained fellowship training in infertility at the Baylor College of Medicine. Dr. Spitz has expertise in treating male infertility and sexual dysfunction and is actively engaged in clinical trials and research in andrology, male sexual dysfunction, and male infertility. Dr. Aaron Spitz served as an assistant clinical professor in the U.C. Irvine department of Urology, specializing in male reproductive medicine and surgery.    Dr. Spitz directs the Male Reproductive Medicine and Surgery Center at Orange County Urology in Laguna Hills and Mission Viejo, California.  Dr. Spitz is the co-Chair of the AUA Telemedicine task force.  He also serves on the AUA Workforce Work Group, the AUA Advanced Practice Practitioner Work Group, and the AUA opioid position statement workgroup. He served as the lead delegate to the American Medical Association House of Delegates, representing the American Urologic Association. He has served as the President of the California Urologic Association. He is the Orange County District representative to the Western Section of the American Urologic Association. Dr. Spitz served on the Board of Directors as Vice President of Finance for the Pacific Coast Reproductive Society. Dr. Spitz also served as treasurer for the Society for the Study of Male Reproduction.   Dr. Spitz has been awarded several prestigious honors, including Alpha Omega Alpha at the University of Southern California and the Distinguishes Service Award from the American Urological Association.  Dr. Spitz is the author of The Penis Book: A Doctor's Complete Guide to the Penis, published by Rodale Books, from size to function. He appears regularly on CBS The Doctors to discuss urology topics. He was also featured in the documentary The Game Changers. He has authored book chapters and articles in peer-reviewed publications on the topic of male infertility and sexual dysfunction as well as on Telemedicine. Dr. Spitz is a member of the AUA, AMA, SSMR, SMRU, ASRM. He serves as a reviewer for the Journal of Endourology, The Journal of Urology, and the Journal of Andrology and Urology Practice.  (https://www.aaronspitz.com/) Music Credit: Woho, I Thought It Be Me & You (ft. Lily Hain) by Leonell Cassio https://soundcloud.com/leonellcassio Creative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0

Testicular Cancer Society Founder - Mike Craycraft The Not Old Better Show, Science Interview Series Welcome to The Not Old Better Show on radio and podcast, today's episode is sponsored by MANSCAPED.  I'm Paul Vogelzang and June is National Men's Health Month! National Men's Health Month is all about encouraging the men in your life (including you, men out there!) to take care of their bodies by eating right, exercising, and working to prevent disease. Because June 2022 is Men's Health Month our conversation with Mike Craycraft.  Mike Craycraft is a testicular cancer survivor, a clinical pharmacist, with a substantial medical and healthcare background, and the founder of the Testicular Cancer Society. Join us today as we discuss Topics including trends in cancer research and treatment for testicular cancer, as well as disparities and challenges in educating young and old, including those in our Not Old Better Show audience here on radio and podcast about the disease.   Learn more about prevention, diagnosis, and treatment for testicular cancer by visiting the  American Urological Association's Testicular Cancer Diagnosis Guideline Update, Cancer.nets's explanation of the disease, including recent data, and some additional testicular cancer statistics from Johns Hopkins. Visit The Not Old Better Show's partner, Manscaped's testicular cancer awareness page, and join me in welcoming to The Not Old Better Show on radio and podcast, Mike Craycraft. My thanks to our sponsor today, MANSCAPED™ for sponsoring today's episode.  June is Men's Health Month, so let's raise awareness of all things health for men by raising awareness for the most common form of cancer in men aged 15-35, providing education about the disease, and giving support for fighters, survivors, and caregivers.  My thanks to you, my wonderful Not Old Better Show audience on radio and podcast.  Please be safe, be well, let's support each other and decry violence…and in so doing, Let's Talk About Better; The Not Old Better Show on radio and podcast.  Thanks, everybody and we'll see you next week.

Featuring perspectives from Drs Raoul Concepcion, Fred Saad and Matthew Smith, moderated by Dr Emmanuel Antonarakis, including the following topics: Introduction (0:00) Management Approaches for Nonmetastatic Prostate Cancer — Raoul S Concepcion, MD (3:00) Role of Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer — Matthew R Smith, MD, PhD (31:55) Selection and Sequencing of Therapy for Metastatic Castration-Resistant Prostate Cancer — Emmanuel S Antonarakis, MD (1:00:03) Current and Future Integration of PARP Inhibitors in the Management of Prostate Cancer — Fred Saad, MD (1:30:29) CME information and select publications

In this week's episode I talk with Jill Osborne, founder of the Interstitial Cystitis Network. We discuss the new changes in the IC world from the American Urological Association, which has recently updated its guidelines on diagnosing and treating IC. Connect with Jill: Website: https://www.ic-network.com/ Instagram: @icnetwork Facebook: @interstitialcystitisnetwork YouTube: https://www.youtube.com/user/icnjill IC Network number: 1.800.928.7496 Link to register for webinar: https://go.callieknutrition.com/1-registration-page-non-diet-triggers Updated AUA Recommendations: https://www.auanet.org/guidelines/guidelines/diagnosis-and-treatment-interstitial-cystitis/bladder-pain-syndrome-(2022) AUA fact sheet: https://www.ic-network.com/new-ic-bps-guidelines-released-in-usa/?fbclid=IwAR3o1gOZEB0olmUoC82MtHKGDaDrLQhYj1RVoxmjiqe6ZpfZu0eI6_kFx68# Road To Remission Program: https://www.callieknutrition.com/road-to-remission IC friendly recipes: www.callieknutrition.com/blog Connect with me! Instagram : https://www.instagram.com/callieknutrition/ Facebook: https://www.facebook.com/callie.krajcir.9 Pinterest: https://www.pinterest.com/callieknutrition/_created/ Website: https://www.callieknutrition.com/ Email: support@callieknutrition.com Apple Podcast: https://podcasts.apple.com/us/podcast/ic-you/id1604016381 Spotify: https://open.spotify.com/show/6a4lQrKBcA31b5uAQpKNPf

Featuring perspectives from Drs Matthew Galsky, Ashish Kamat and Stephen Williams, moderated by Dr Sumanta Kumar Pal, including the following topics: Introduction (0:00) Available Data with and Ongoing Investigation of Novel Agents and Strategies for Non-Muscle-Invasive Bladder Cancer (NMIBC) — Ashish M Kamat, MD, MBBS (2:17) Novel Therapeutic Approaches for Muscle-Invasive Bladder Cancer (MIBC) — Stephen B Williams, MD, MS (33:41) Current and Future Front-Line Management of Metastatic Urothelial Bladder Carcinoma (mUBC) — Matthew D Galsky, MD (1:00:55) Selection and Sequencing of Therapy for Relapsed/Refractory mUBC — Sumanta Kumar Pal, MD (1:43:07) CME information and select publications

The American Urological Association just announced new Guidelines for the treatment of interstitial cystitis.  It's the first update in 7 years, and it's big for pelvic rehab professionals!We basically have an entire category of treatment ("behavioral and non-pharmacological") that we are unique qualified to administer.Among the highlights (and things we've been advocating for...The AUA specifically calls out that Kegel exercises should not be done for patients with ICAdditional studies showing Elmiron has limited efficacy (or, in several trials, no efficacy at all) in treating IC over a placebo, as well as the chance for long-term eye damageAcknowledging an elimination diet (and not the 'IC Diet') is the gold standard for nutritional careHere's the link to the new AUA Guidelines for IC - hope you enjoy the 'sode!IC: Holistic Evaluation & TreatmentIf you're looking for the resource to go through all the physical therapy treatments, demonstrations of techniques on patients, medical management and everything you need to quarterback your patient's care, check out the IC: Holistic Evaluation & Treatment course! (www.pelvicptrising.com/ic)Pelvic PT Rising Business Mentorship - New Cohort!For the first time in over a year we are offering new spots in our Business Mentorship to cash-based pelvic health providers!  Our mentees on average have doubled their case load and increased revenue by over $125,000 in the first year of working with us!  We have 25 new spots available - for more information or to apply, visit www.pelvicptrising.com/mentoring.Shout Out and Get in Touch!If you're enjoying the podcast, please take a few seconds to take a screenshot and put it up in your Instagram Stories and tag Nicole (@nicolecozeandpt).  Or send us an email at Nicole@PelvicSanity.com with your thoughts, questions or ideas.  We'd love to hear from you!About UsNicole and Jesse Cozean founded PelvicSanity Physical Therapy together in 2016.  It grew quickly into one of the largest cash-based physical therapy practices in the country.  They run Pelvic PT Rising, providing both clinical and business resources exclusively tailored to pelvic PTs.

Paul Maroni is a urologic oncologist at University of Colorado in Denver.  He also runs the American Urological Association course on “Winning the Battle Against Burnout.”  Paul is also an extremely thoughtful and mindful surgeon, physician, and educator.  In this episode of OWZ, we tackle a lot more than burnout.  We discuss extreme ownership of the good and bad that occurs in our surgical practices, we talk about putting successes and failures into perspective, and, in Paul's own words, we seek to find “joy serving others.”  We would be lying if we said everyday as a surgeon is amazingly positive.  But everyday can be amazing with the right perspective and approach. (Music Credit: Sunshine, Simon Jomphe Lepine.)

We talk with urologist Dr. Jay Shah, leader of urologic oncology at the Stanford Cancer Center, about seizing leadership opportunities in the world of academic medicine. --- CHECK OUT OUR SPONSOR DI4MDs Protect your most valuable asset, the skill and ability to practice your medical specialty. Be prepared by establishing a specialty specific disability insurance policy from the experts at DI4MDs. Contact them today at www.Di4MDS.com or call 888-934-4637. --- EARN CME Reflect on how this Podcast applies to your day-to-day and earn AMA PRA Category 1 CMEs: https://earnc.me/voLZNT --- SHOW NOTES In this episode of BackTable Urology, Dr. Aditya Bagrodia interviews urologist Dr. Jay Shah, leader of urologic oncology at the Stanford Cancer Center, about seizing leadership opportunities in the world of academic medicine. First, the doctors discuss the importance of finding a niche for their medical practice and research. Dr. Shah encourages young faculty members to identify a specific interest within their field and start research related to that topic. Although it was hard for him to prioritize his niche at first, he realized that gaining knowledge in quality improvement, his chosen niche, was much easier when he merged both his clinical and academic work. Then, Dr. Shah and Dr. Bagrodia discuss the challenges of a mid-career change. Dr. Shah moved from MD Anderson to Stanford, while Dr. Bagrodia moved from UT Southwestern to UC San Diego. Both doctors agreed that changing institutional cultures and practices can be daunting; however, they noted that it was important to build credibility and to keep an open mind about listening to the ideas of their new colleagues. Dr. Shah believes that new faculty may take up to four years at their new institution before they start to feel comfortable in their new position. Dr. Bagrodia then warns against having unrealistic nostalgia for old institutions. Finally, the doctors suggest ways to build leadership skills and gain leadership experience within the field of urology. Both doctors found leadership courses and having an executive leadership coach helpful. They also encourage young urologists to get involved in committees of urological societies, including the American Urological Association.

In this episode we discuss robotic radical prostatectomy as a treatment option for prostate cancer. Over the last 20 years, robotic radical prostatectomy has become the gold standard for surgical management of prostate cancer.  While the concept of robotic surgery is exciting, it also leads to a lot of questions amongst men faced with a decision as to how to treat their prostate cancer.  How does the procedure actually work?  Is the surgery performed by a surgeon or by a robot?  What are the risks and side effects? Are all men good candidates for the procedure.  And, of course, how effectively does it cure prostate cancer?  To answer these questions we turned to Dr. Alexander Kutikov.  Dr. Kutikov is a Professor and Chief of Urology and Urologic Oncology at the Fox Chase Cancer Center. He is a board certified, academic urologic surgical oncologist who treats urologic tumors using minimally invasive (robotic / laparoscopic) and traditional surgical techniques. Dr. Kutikov received an MD from Harvard Medical School's Harvard-MIT Health Sciences and Technology Program in 2003. He then completed his Urologic residency training at the University of Pennsylvania in 2008 and finished a 2-year Society of Urologic Oncology fellowship at the Fox Chase Cancer Center in Philadelphia, USA. He has co-authored more than 170 original manuscripts in peer-reviewed journals and has published chapters in leading urologic textbooks as well as holding leadership positions both in the American College of Surgeons and the American Urological Association.

In this episode we discuss penile enlargement.  A recent study revealed that 45% of men wish that their penises were larger. That desire is further confirmed by the multitudes of creams, medications, and procedures promising to increase the length and/or the girth of the penis.  But is it actually possible to increase the size of the penis? Do any of these treatments actually work?  And, if so, to what extent?  What are the risks of these penile enhancement treatments?  And are there trade offs involved?  To answer these questions, we are fortunate to be joined by Dr. Matthew Ziegelmann.  Dr. Ziegelmann is an Assistant Professor specializing in male sexual dysfunction and infertility (Andrology) in the Department of Urology at the Mayo Clinic. He obtained his medical degree from the University of Minnesota and then completed a residency in urology at Mayo Clinic in Rochester, MN. He then continued his sub-specialty training in male sexual dysfunction and infertility (Andrology) at Rush University Medical Center in Chicago, IL. He is an active member of the American Urological Association, North Central Section, and Sexual Medicine Society of North America. He has published extensively in male sexual dysfunction and speaks nationally on topics related to male sexual dysfunction and other urologic conditions.

In this episode we discuss the relationship between COVID and male sexual health.  As if COVID has not caused enough problems, we are now learning that it can creep into our bedrooms as well.  Anybody on social media can tell you that there are all sorts of claims about the impact of COVID on the sex lives of men. And, just in case you weren't confused and worried enough, those claims are often conflicting.  While some claim that COVID can cause problems ranging from erectile dysfunction to infertility, other claim that it's the COVID vaccines (rather than COVID itself) that are causing the problems. So who do we believe?  What do we know to be true versus what we think is true vs what may not be true vs what we know to be just pure nonsense? To help us sort the facts from the fiction, we are fortunate to be joined by Dr. Rena Malik. Dr. Malik is Assistant Professor of Surgery in the Division of Urology at the University of Maryland. She completed her training at the University of Chicago and the University of Texas at Southwestern Medical Center. She is currently a member of the American Urological Association and the Society of Women in Urology. She has published over 20 peer-review articles and book chapters. She also has a very popular YouTube channel dedicated to men's health that currently educates and entertains over 700,000 subscribers. And now, without further ado, I bring you our conversation with Dr. Renal Malik about the relationship between COVID and male sexual health.

Guest: Aaron M. Potretzke, M.D. (@potretzke) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Microscopic hematuria, and less commonly gross hematuria, are conditions commonly seen by the primary care provider. Malignancy is the most ominous cause of hematuria. Fortunately, other causes are much more likely. Since this is a relatively common health condition, when should we investigate hematuria and what should the evaluation consist of? How do we evaluate a patient's risk for urinary tract malignancy? Dr. Aaron Potretzke, a urologist at Mayo Clinic joins us to discuss these questions. Specific topics: Definition of hematuria Benign causes of hematuria Risk of malignancy in low, medium, and high-risk patients Stratifying malignancy risk in patients for genitourinary malignancy Recommended evaluation for patients with hematuria How to manage patients with persistent hematuria despite a negative evaluation Role of urine cytology in the evaluation of hematuria Additional resources: American Urological Association hematuria guideline and algorithm: https://www.auanet.org/guidelines/guidelines/microhematuria Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

This episode features Dr. Joseph Sonstein, MD. He completed his medical school and residency training at UTMB in Galveston, Texas. He currently serves as the program director for urology and as an associate professor in urology at UTMB.In this episode, we get a program director's opinion on what it's like to apply to urology and things students should keep in mind. We discuss STEP1, personal statements, letters of recommendation, and more!RESOURCES:UroResidency (https://uroresidency.com/resources)Urology Match (https://www.urologymatch.com/) American Urological Association (https://www.auanet.org/)Society of Academic Urologists (https://sauweb.org/home.aspx)EMAIL:Dr. Sonstein: josonste@utmb.eduME: atmeffor@utmb.edu 

The outcomes of prostate cancer can differ vastly. Some patients have slow-growing cancer that will never threaten their health, while others have aggressive cancer that progresses quickly. Urologists have a variety of new tools available to help them match the patient with the right course of treatment. Those tools range from cutting-edge tests to expose the molecular basis of the cancer to imaging techniques that can allow for the precise targeting of the cancer. A urologist who understands the use and limitations of those tools is critical for attaining the best outcomes.  We have a very special guest joining us today! We are happy to welcome Dr. Chris Barbieri, a urologist from Weill Cornell Medicine! The above opening statement was taken from his personal statement, and he remains committed to it. He also remains at the forefront of prostate cancer care in the 21st century.  Dr. Christopher Barbieri attended Vanderbilt University School of Medicine, where he obtained both his MD and Ph.D. degrees. He completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a specific focus on prostate cancer. His work has led to recognition as a Prostate Cancer Foundation Young Investigator and a Urology Care Foundation Research Scholar; he is also the recipient of a Career Development Award from the National Cancer Institute to fund his work on prostate cancer.  In addition, Dr. Barbieri has also been recognized as a Rising Star in Urology Research by the American Urological Association, and with a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation. He is a prostate cancer surgeon and a highly active researcher in prostate cancer genomics in the Sandra and Edward Meyer Cancer Center at Weill Cornell. That has allowed him to stay at the forefront of prostate cancer in the 21st century and deliver the best possible care to his patients. Be sure to stay tuned for more! Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Barbieri explains why there is no one-size-fits-all solution when it comes to prostate cancer treatment. Some of the initial factors can be looked at to distinguish between men with low-risk prostate cancer and those with higher-risk disease. Dr. Barbieri explains how patients can be better guided in determining which cancers might be more aggressive versus those that might be less aggressive. The difference between genomic testing and genetic testing for prostate cancer. Dr. Barbieri discusses various scenarios related to genomic testing. Dr. Barbieri explains how genomic testing helps him counsel men in the grey area of cancers that can safely be observed after a biopsy versus more serious forms of prostate cancer. Dr. Barbieri does not advocate for any specific genomic test or company. They are all reliable with good performance characteristics. Dr. Barbieri talks about the role that genomic testing for prostate cancer plays for men who have already undergone a radical prostatectomy. There are many new and exciting developments happening in the field of prostate cancer. Dr. Barbieri urges men to keep themselves informed of those. Links: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link here, on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.